Skip to main content

Hepion Pharmaceuticals, Inc.

HEPA
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001583771

In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.

Other share classesCTRVP

13F holders, Q3 2021

Institutional positions in Hepion Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
42
−6 vs. Q2 2021
Shares held
7.80M
−2.96M (−27.5%) vs. Q2 2021
Total value
$11.9M
−$9.34M (−43.9%) vs. Q2 2021
New holders
5
7 more added
Sold out
11
15 more reduced

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HEPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 42 institutions
Q1 2021: 45 institutionsQ2 2021: 49 institutionsQ3 2021: 42 institutionsQ4 2021: 43 institutionsQ1 2022: 38 institutionsQ2 2022: 34 institutionsQ3 2022: 32 institutionsQ4 2022: 32 institutionsQ1 2023: 32 institutionsQ2 2023: 23 institutionsQ3 2023: 24 institutionsQ4 2023: 24 institutionsQ1 2024: 25 institutionsQ2 2024: 24 institutionsQ3 2024: 22 institutionsQ4 2024: 22 institutionsQ1 2025: 16 institutionsQ2 2025: 4 institutionsQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2021: $11.9M
Q1 2021: $14.7MQ2 2021: $21.3MQ3 2021: $11.9MQ4 2021: $9.00MQ1 2022: $9.74MQ2 2022: $4.24MQ3 2022: $3.61MQ4 2022: $2.20MQ1 2023: $5.60MQ2 2023: $5.43MQ3 2023: $4.00MQ4 2023: $2.42MQ1 2024: $1.77MQ2 2024: $863.9KQ3 2024: $338.2KQ4 2024: $215.4KQ1 2025: $419.7KQ2 2025: $1.39KQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding HEPA and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20254$1.39K
Q1 202516$419.7K
Q4 202422$215.4K
Q3 202422$338.2K
Q2 202424$863.9K
Q1 202425$1.77M
Q4 202324$2.42M
Q3 202324$4.00M
Q2 202323$5.43M
Q1 202332$5.60M
Q4 202232$2.20M
Q3 202232$3.61M
Q2 202234$4.24M
Q1 202238$9.74M
Q4 202143$9.00M
Q3 202142$11.9M
Q2 202149$21.3M
Q1 202145$14.7M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Hepion Pharmaceuticals, Inc.; share changes are against Q2 2021.

Institutions holding HEPA in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc3,330,741$5.10M0.00%00.0%Unchanged
BlackRock Inc.1,634,012$2.50M0.00%−15,917−1.0%Reduced
Geode Capital Management, LLC658,110$1.01M0.00%+6,792+1.0%Added
Ikarian Capital, LLC553,273$847.0K0.19%−811,786−59.5%Reduced
State Street Corp322,716$494.0K0.00%00.0%Unchanged
Northern Trust Corp143,428$220.0K0.00%−2,087−1.4%Reduced
Asset Management Corp133,500$204.0K0.13%+42,000+45.9%Added
Two Sigma Advisers, LP123,000$188.0K0.00%−748,200−85.9%Reduced
Susquehanna International Group, LLP115,152$176.0K0.00%−123,014−51.7%Reduced
Bank of New York Mellon Corp89,094$136.0K0.00%+45,270+103.3%Added
McAdam, LLC55,978$86.0K0.01%00.0%Unchanged
Boothbay Fund Management, LLC55,599$85.0K0.00%−99,470−64.1%Reduced
PVG Asset Management Corp51,989$79.5K0.24%−137,627−72.6%Reduced
Susquehanna Fundamental Investments, LLC49,800$76.0K0.00%−38,800−43.8%Reduced
UBS Group AG48,351$74.0K0.00%+25,346+110.2%Added
The PNC Financial Services Group, Inc.39,034$60.0K0.00%+39,034New
Envestnet Asset Management Inc38,418$59.0K0.00%−54,501−58.7%Reduced
ExodusPoint Capital Management, LP36,878$56.0K0.00%+14,704+66.3%Added
Morgan Stanley35,036$54.0K0.00%−56,070−61.5%Reduced
HRT Financial LP35,058$53.0K0.00%+24,599+235.2%Added
Charles Schwab Investment Management Inc31,535$49.0K0.00%00.0%Unchanged
Bank of America Corp32,004$49.0K0.00%+31,211+3,935.8%Added
Prospera Financial Services Inc30,300$46.0K0.00%00.0%Unchanged
Group One Trading, L.P.28,624$44.0K0.00%−48,075−62.7%Reduced
Citadel Advisors LLC26,489$40.0K0.00%−31,120−54.0%Reduced
Advisor Group Holdings, Inc.16,604$25.0K0.00%−1,147−6.5%Reduced
Qube Research & Technologies Ltd16,279$25.0K0.00%+16,279New
JGP Wealth Management, LLC15,000$23.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc11,555$18.0K0.00%−56,844−83.1%Reduced
Quilter Plc11,045$17.0K0.00%00.0%Unchanged
Fort Point Capital Partners LLC10,000$15.0K0.00%+10,000New
Benjamin F. Edwards & Company, Inc.6,501$10.0K0.00%00.0%Unchanged
Geneos Wealth Management Inc.5,000$7.00K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec3,500$5.36K0.00%00.0%Unchanged
Migdal Insurance & Financial Holdings Ltd.2,607$4.00K0.00%+2,607New
US Bancorp1,000$2.00K0.00%+1,000New
Wells Fargo & Company467$1.00K0.00%−25−5.1%Reduced
Rockefeller Capital Management L.P.1,000$1.00K0.00%00.0%Unchanged
Signaturefd, LLC2$00.00%00.0%Unchanged
Harbor Investment Advisory, LLC1$00.00%00.0%Unchanged
Capital Advisors, Ltd. LLC1$00.00%00.0%Unchanged
BerganKDV Wealth Management, LLC1$00.00%00.0%Unchanged
Altium Capital Management LP0$00.00%−446,000−100.0%Sold out
Two Sigma Investments, LP0$00.00%−245,007−100.0%Sold out
Virtu Financial LLC0$00.00%−113,869−100.0%Sold out
Meitav Dash Investments Ltd0$00.00%−50,000−100.0%Sold out
Zeke Capital Advisors, LLC0$00.00%−50,000−100.0%Sold out
Moloney Securities Asset Management, LLC0$00.00%−27,340−100.0%Sold out
Allen Capital Group, LLC0$00.00%−23,685−100.0%Sold out
Jane Street Group, LLC0$00.00%−18,328−100.0%Sold out
Bank Julius Baer & Co. Ltd, Zurich0$00.00%−13,131−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−3,418−100.0%Sold out
Prentice Wealth Management LLC0$00.00%−250−100.0%Sold out
San Francisco Sentry Investment Group (Ca)––––Not filed